LENZ vs MSCI · rev $7.4M vs P/E 37, rev $1.72B
LENZ Therapeutics Inc (LENZ) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
LENZ currently screens at market cap $223.6M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the LENZ and MSCI stock pages for the full models.
Not investment advice.